Status:

COMPLETED

Role of Anti-IgE in Severe Childhood Eczema

Lead Sponsor:

Guy's and St Thomas' NHS Foundation Trust

Collaborating Sponsors:

King's College London

National Institute for Health Research, United Kingdom

Conditions:

Atopic Eczema

Atopic Dermatitis

Eligibility:

All Genders

4-19 years

Phase:

PHASE4

Brief Summary

To evaluate the efficacy of anti-IgE (Omalizumab/Xolair) in children with severe eczema.

Detailed Description

To address the value of anti-IgE in children with severe eczema.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Children between the ages of 4-19 years
  • Severe eczema
  • Raised SpIgE or SPT to at least 1 food allergen or 1 aeroallergen AND/OR
  • Clinical impression that allergic exposures cause worsening eczema.
  • Total IgE level \>300 kU/l
  • Clinically proven IgE-mediated allergic disease.
  • Written informed consent to participate.
  • Exclusion criteria:
  • Inability to comply with 2-4 weekly injections and clinic visits
  • Evidence of underlying immune compromise, autoimmune disease, immune complex mediated conditions.
  • Uncontrolled infection or unstable eczema.
  • Malignancy or a history of malignancy.
  • Pre-existing hepatic or renal impairment
  • Known cardiovascular or ischaemic cerebrovascular abnormality.
  • Other serious or uncontrolled systemic disease.
  • Pregnancy or lactation.
  • Known history of hypersensitivity or anaphylaxis to anti-IgE injections or its constituents.
  • Insufficient understanding of the trial assessments.
  • Participation in a CTIMP in the previous 60 days or (if known) 4 half-lives of the relevant medication, whichever is the greater.
  • Investigator feels that there is a good clinical reason why the child would be unsuitable.

Exclusion

    Key Trial Info

    Start Date :

    December 1 2014

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 1 2018

    Estimated Enrollment :

    62 Patients enrolled

    Trial Details

    Trial ID

    NCT02300701

    Start Date

    December 1 2014

    End Date

    August 1 2018

    Last Update

    August 9 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Guy's and St Thomas' NHS Foundation Trust

    London, United Kingdom, SE1 7EH